ScoreWhy is Ajooni Biotech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.76%
- Poor long term growth as Operating profit has grown by an annual rate 18.06% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.96
2
Below par performance in long term as well as near term
- Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ajooni Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ajooni Biotech
-46.79%
-1.23
37.65%
Sensex
7.31%
0.65
11.21%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.82%
EBIT Growth (5y)
18.06%
EBIT to Interest (avg)
1.96
Debt to EBITDA (avg)
1.82
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
1.52
Tax Ratio
23.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.46%
ROE (avg)
4.00%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.74
EV to EBIT
19.58
EV to EBITDA
14.32
EV to Capital Employed
0.72
EV to Sales
0.47
PEG Ratio
0.26
Dividend Yield
NA
ROCE (Latest)
3.66%
ROE (Latest)
4.43%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 7.98 times
NET SALES(Q)
Highest at Rs 58.75 cr
PBDIT(Q)
Highest at Rs 3.03 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 5.16%
PBT LESS OI(Q)
Highest at Rs 2.04 cr.
PAT(Q)
Highest at Rs 1.65 cr.
-1What is not working for the Company
EPS(Q)
Lowest at Rs 0.10
Loading Valuation Snapshot...
Here's what is working for Ajooni Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.04 cr has Grown at 229.03%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
At Rs 58.75 cr has Grown at 72.64%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
Highest at Rs 58.75 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 3.03 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 5.16%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 2.04 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.65 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 7.98 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Ajooni Biotech
Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.10
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
